OS Therapies (NYSEMKT: OSTX)
$2.00
(-8.1%)
-$0.18
Price as of August 19, 2025, 11:37 a.m. ET
OS Therapies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
OS Therapies Company Info
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.